| (Values in U.S. Thousands) | Sep, 2025 | Jun, 2025 | Mar, 2025 | Sep, 2024 | Jun, 2024 |
| Sales | 1,338,000 | 1,466,000 | 1,601,000 | 1,483,000 | 1,598,000 |
| Sales Growth | -8.73% | -8.43% | +7.96% | -7.20% | -4.77% |
| Net Income | -77,000 | -45,000 | -57,000 | -64,000 | 1,000 |
| Net Income Growth | -71.11% | +21.05% | +10.94% | -6,500.00% | +106.25% |
Lanxess Ag (LXS.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Lanxess AG is a German chemical company that was originally spun out of Bayer. Lanxess has visibly decommoditised its portfolio by divesting its synthetic rubber business. It has business segments namely: specialty chemicals company in the fields of consumer protection chemicals, specialty additives, intermediates, and others. Geographically, it operates in EMEA (excluding Germany), Germany, Americas, and Asia-Pacific.
Fiscal Year End Date: 12/31